Cincera Therapeutics is a privately held biotechnology company.
Cincera Therapeutics has raised $327K in total funding. The most recent round was Grant. The last funding was announced in May 2023.
Cincera Therapeutics's investors include Brandon Capital, Brandon BioCatalyst, Medical Research Commercialisation Fund (MRCF).
Cincera Therapeutics is headquartered in Melbourne, Australia.
Cincera Therapeutics is a privately held biotechnology company.
Cincera Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cincera Therapeutics — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/cincera-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Cincera Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cincera-therapeutics
{{cite web |title=Cincera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cincera-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated